Clinical Trial Update: S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction [Phase 3]

View source ↗

Summary

Phase 3 trial update for S086 tablets in chronic heart failure with reduced ejection fraction (HFrEF) currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• S086

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Chronic Heart Failure With Reduced Ejection Fraction | Phase 3 | Status: RECRUITING